EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Prognostic Value of Cancer Stem Cell Markers (CSCs) Expression—ALDH1A1, CD133, CD44—For Survival and Long-Term Follow-Up of Ovarian Cancer Patients

Natalia Izycka, Marcin Rucinski iD, Malgorzata Andrzejewska, Sebastian Szubert, Ewa Nowak-Markwitz, Karolina Sterzynska iD

International Journal of Molecular Sciences · 25.01.2023 · 24 (3) · 2400

DOI: 10.3390/ijms24032400 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.01.2023. Verfasst von Natalia Izycka und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Obstetrics and Gynecologic Oncology, Division of Gynecologic Oncology, Poznan University of Medical Sciences, Polna 33 St.,…. Hauptthemen laut MEDLINE: Hyaluronan Receptors, Ovarian Neoplasms. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recurrent disease and treatment-associated chemoresistance are the two main factors accounting for poor clinical outcomes of ovarian cancer (OC) patients. Both can be associated with cancer stem cells (CSCs), which contribute to cancer formation, progression, chemoresistance, and recurrence. Hence, this study investigated whether the expression of known CSC-associated markers ALDH1A, CD44, and CD133 may predict OC patient prognosis. We analyzed their expression in primary epithelial ovarian cancer (EOC) patients using immunohistochemistry and related them to clinicopathological data, including overall survival (OS) and progression-free survival (PFS). Expression of ALDH1A1 was detected in 32%, CD133 in 28%, and CD44 in 33% of cases. While Kaplan–Meier analysis revealed no association of the expression of CD133 and CD44 with PFS and OS, ALDH1A1-positive patients were characterized with both significantly shorter OS (p = 0.00022) and PFS (p = 0.027). Multivariate analysis demonstrated that the expression of ALDH1A1, FIGO stage III–IV, and residual disease after suboptimal debulking or neoadjuvant chemotherapy correlated with shorter OS. The results of this study identify ALDH1A1 as a potential independent prognostic factor of shorter OS and PFS in EOC patients. Therefore, targeting ALDH1A1-positive cancer cells may be a promising therapeutic strategy to influence the disease course and treatment response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyaluronan ReceptorsOvarian NeoplasmsFemaleHumansAldehyde Dehydrogenase 1 FamilyBiomarkers, TumorCarcinoma, Ovarian EpithelialFollow-Up StudiesNeoplastic Stem CellsPrognosisRetinal DehydrogenaseAC133 Antigen

Stichwörter der Autor:innen

ALH1A1CD133CD44cancer stem cellsepithelial ovarian cancerprognosis biomarker

Substanzen

Aldehyde Dehydrogenase 1 FamilyBiomarkers, TumorHyaluronan ReceptorsRetinal DehydrogenaseALDH1A1 protein, humanCD44 protein, humanPROM1 protein, humanAC133 Antigen

Autor:innen und Institutionen

  • Department of Gynecology, Obstetrics and Gynecologic Oncology, Division of Gynecologic Oncology, Poznan University of Medical Sciences, Polna 33 St., 60-535 Poznań, Poland.
  • Department of Histology and Embryology, Poznan University of Medical Sciences, Święcickiego 6 St., 61-781 Poznań, Poland.

ORCID-Profile: Marcin Rucinski, Karolina Sterzynska

Zitieren

APA

Izycka, N., Rucinski, M., Andrzejewska, M., Szubert, S., Nowak-Markwitz, E., & Sterzynska, K. (2023). The Prognostic Value of Cancer Stem Cell Markers (CSCs) Expression—ALDH1A1, CD133, CD44—For Survival and Long-Term Follow-Up of Ovarian Cancer Patients. International Journal of Molecular Sciences, 24(3), 2400. https://doi.org/10.3390/ijms24032400

Vancouver

Izycka N, Rucinski M, Andrzejewska M, Szubert S, Nowak-Markwitz E, Sterzynska K. The Prognostic Value of Cancer Stem Cell Markers (CSCs) Expression—ALDH1A1, CD133, CD44—For Survival and Long-Term Follow-Up of Ovarian Cancer Patients. International Journal of Molecular Sciences. 2023;24(3):2400. doi:10.3390/ijms24032400

BibTeX
@article{Izycka2023,
  author = {Izycka, Natalia and Rucinski, Marcin and Andrzejewska, Malgorzata and Szubert, Sebastian and Nowak-Markwitz, Ewa and Sterzynska, Karolina},
  title = {The Prognostic Value of Cancer Stem Cell Markers (CSCs) Expression—ALDH1A1, CD133, CD44—For Survival and Long-Term Follow-Up of Ovarian Cancer Patients},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {3},
  pages = {2400},
  doi = {10.3390/ijms24032400}
}
Kostenlos starten →